Collection
Serial/Series Title
Year
1 Matching Results
Results open in a new window/tab.
Results:
1 - 1 of
1
[News Release: FDA Advisory Committe Recommends Approval of Retrovir (AZT) for HIV-Positive Pregnant Wome and Infants]
A news release from Burrough Wellcome Co. about their brand of zidovudine (AZT), Retrovir, being approved by the FDA to reduce the risk of HIV transmission from pregnant mothers to their infants.
Date:
1987
Creator:
Burroughs Wellcome Co.
System:
The UNT Digital Library